PAR26 COST-UTILITY OUTCOMES SIMULATION MODEL FOR OSTEOARTHRITIS (OA) AND RHEUMATOID ARTHRITIS (RA) PATIENTS (COSMO)- DEVELOPMENT AND VALIDATION OF A PHARMACOECONOMIC MODEL
Abstract
Authors
L Niculescu AW Using PJ Neumann
L Niculescu AW Using PJ Neumann
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now